Welcome to LookChem.com Sign In|Join Free

CAS

  • or

749191-14-8

749191-14-8

Post Buying Request

749191-14-8 Suppliers

Recommended suppliersmore

This product is a nationally controlled contraband, and the Lookchem platform doesn't provide relevant sales information.

749191-14-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 749191-14-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,4,9,1,9 and 1 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 749191-14:
(8*7)+(7*4)+(6*9)+(5*1)+(4*9)+(3*1)+(2*1)+(1*4)=188
188 % 10 = 8
So 749191-14-8 is a valid CAS Registry Number.

749191-14-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(7-methyl-1,3-benzodioxol-5-yl)propan-2-amine

1.2 Other means of identification

Product number -
Other names 5-Methyl-3,4-methylenedioxyamphetamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:749191-14-8 SDS

749191-14-8Downstream Products

749191-14-8Relevant articles and documents

Synthesis and pharmacological evaluation of ring-methylated derivatives of 3,4- (Methylenedioxy) amphetamine (MDA)

Parker, Matthew A.,Marona-Lewicka, Danuta,Kurrasch, Deborah,Shulgin, Alexander T.,Nichols, David E.

, p. 1001 - 1005 (1998)

The three isomeric ring-methylated derivatives of the well-known hallucinogen and entactogen MDA (la) were synthesized and evaluated for pharmacological activity as monoamine-releasing agents and as serotonin agonists. The 2-methyl derivative 2a and the 5-methyl derivative 2b were found to be more potent and more selective than the parent compound in inhibiting [3H]-serotonin accumulation in rat brain synaptosomal preparations. Their activity in vivo was confirmed in rats trained to discriminate serotonin-releasing agents and hallucinogens from saline. The results indicate that compounds 2a,b are among the most potent 5-HT-releasing compounds known and show promise as lead compounds in the search for antidepressant drugs that release serotonin rather than inhibit its uptake.